相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer
F. Gregory Buchanan et al.
CANCER RESEARCH (2007)
Cardiovascular events associated with the use of four nonselective NSAIDs (Etodolac, Nabumetone, Ibuprofen, or Naproxen) versus a cyclooxygenase-2 inhibitor (Celecoxib): A population-based analysis in Taiwanese adults
Weng-Foung Huang et al.
CLINICAL THERAPEUTICS (2006)
Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population
C. Huerta et al.
HEART (2006)
Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study
M Hudson et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs -: A population-based case-control study
SP Johnsen et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
DJ Graham et al.
LANCET (2005)
Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model
ZF Yang et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2004)
Risk of cardiovascular events associated with selective COX-2 inhibitors
D Mukherjee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
